Cervical Cancer Treatment

During more than 40 years of cervical cancer treatment and clinical administration, the autologous vaccine has contributed to the retardation, cessation and remission of tumor growth in a variety of advanced diseases. This cervical cancer treatment vaccine contributes to the resolution of painful chronic inflammation in joints, healing of chronic lesions and sores. The vaccine is non-toxic and sterile. Since it is custom prepared from the patient's own blood, many of the systemic side effects typically associated with other cervical cancer treatment programs are not experienced. A slight rise in temperature, fatigue, and tenderness in the tumor area are possible for a short period after administration of our cervical cancer treatment vaccine.